Vanderbilt University

Irene Zagol-Ikapitte

Olivier Boutaud

John A Oates

A method of preventing or reducing the occurrence of malondiadehyde and/or levuglandin protein modification in a subject in need thereof, comprising administering to said subject an effective amount of at least one reactive dicarbonyl scavenger compound, or a pharmaceutically acceptable salt thereof.

Methods of preventing platelet activation

A method of preventing or reducing the occurrence of malondiadehyde and/or levuglandin protein modification in a subject in need thereof, comprising administering to said subject an effective amount of at least one &#x3b3;-KA scavenger compound, or a pharmaceutically acceptable salt thereof.

Growing community of inventors

Nashville, TN, United States of America

Irene Zagol-Ikapitte